Protecting against HIV vaccine misinformation with young women in South Africa

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202503620653231

Enrollment

3000

Registered

2025-03-14

Start date

2025-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Control arm Nutritional information

Enhanced inoculation message

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female Age 18-24 years Self-reported history of sexual activity in the past 12 months Self-reported HIV-negative status or unknown HIV status at enrolment Willing and able to provide written informed consent Able to read and understand English

Exclusion criteria

Exclusion criteria: Unwilling or unable to provide consent for study participation.

Design outcomes

Primary

Measure	Time frame
Intention to receive the HIV vaccine following exposure to misinformation	—

Secondary

Measure	Time frame
Secondary outcomes: (1) intention to receive the HIV vaccine 2-6 weeks following the exposure, believability and persuasiveness of misinformation, interest in sharing misinformation, and motivational threat associated with misinformation; (2) We will explore subgroup effects by relevant sociodemographic and behavioural factors including HIV risk, PrEP history, COVID-19 vaccine history, general vaccine	—

Measure

Time frame

Secondary outcomes: (1) intention to receive the HIV vaccine 2-6 weeks following the exposure, believability and persuasiveness of misinformation, interest in sharing misinformation, and motivational threat associated with misinformation; (2) We will explore subgroup effects by relevant sociodemographic and behavioural factors including HIV risk, PrEP history, COVID-19 vaccine history, general vaccine

—

Countries

South Africa

Contacts

Public ContactCandice Chetty Makkan

Principal Researcher and Indlela Co Director

cchetty@heroza.org27832892181

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026